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Instant blood-mediated inflammatory reaction (IBMIR) causes rapid islet loss in portal vein islet transplanta-
tion. Endothelial cells are known to protect against complement-mediated lysis and activation of coagulation.
We tested composite pig islet–human endothelial cell grafts as a strategy to overcome IBMIR. Porcine islets
were cocultured with human endothelial cells in specially modified culture medium composed of M199 and
M200 for 1–9 days. A positive control group, negative control group, and the endothelial cell-coated group
were examined with an in vitro tubing loop assay using human blood. The endothelial cell-coated group was
subdivided and analyzed by degree of surface coverage by endothelial cells (≤50% vs. >50%) or coculture
time (<5 days vs. ≥ 5 days). Platelet consumption and complement and coagulation activation were assessed
by platelet count, C3a, and thrombin–antithrombin complex (TAT), respectively. After 60-min incubation
in human blood, the endothelial cell-coated group showed platelet consumption inhibition and low C3a and
TAT assay results compared to uncoated controls. When the endothelial cell-coated group was subdivided
by degree of surface coverage, the ≤50% coated group showed less platelet consumption and less activation
of complement and coagulation compared with the positive control (uncoated) group. On analysis by cocul-
ture time, only the subgroup cocultured for <5 days showed the same protective effect. Human endothelial
cell-coated pig islets, especially the partially coated and short-term cocultured pig islet–human endothelial
cell composites, reduced all components of IBMIR. If the optimal endothelial cell–islet coculture method
could be identified, human endothelial cell coating of pig islets would offer new strategies to improve
xenogenic islet transplantation outcomes.
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INTRODUCTION commonly used agent in clinical islet transplantation.
However, administration of heparin may cause compli-
cations such as bleeding (19) and lacks the ability toIn the clinical setting, pancreatic islet transplantation
is performed via the portal vein. The majority of trans- inhibit complement activation of xenogeneic IBMIR (4).
Coating of pig islets with human endothelial cellsplanted human islets are destroyed before engraftment
(11) by instant blood-mediated inflammatory reaction might have several advantages to overcome IBMIR.
First, the endothelial lining of blood vessels can endure(IBMIR) (3), which may even be stronger in the setting
of xenografts because of species barrier (2,4). direct contact with blood under normal conditions (15).
In addition, human endothelial cells coating of pig isletsMany strategies have been developed for overcoming
IBMIR. Among these, heparin treatment is the most may hide cross-species molecular incompatibilities. Sec-
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ond, endothelial cells have potent effects on angiogen- harvested using 1× trypsin-EDTA (GIBCO BRL, In-
vitrogen). The HAEC were washed with M200 medium,esis (9,13), which should provide a synergistic effect on
islet engraftment. Third, inhibition of the interaction be- centrifuged at 180 × g for 5 min using a 14-ml Falcon
tube (Becton-Dickinson Labware, Lincoln Park, NJ,tween pig islets and human blood will result in de-
creased inflammation, reducing the severity of rejection USA), and counted in a Burker chamber. After washing,
the HAEC were suspended in M200 medium to 3 × 106later in the course (5). Previously, composite human is-
let–endothelial cell grafts showed beneficial effect in an cells/ml. Ten thousand islet equivalents (IEQ) were
mixed together with 3 × 106 HAEC in 300 µl modifiedin vitro model for investigating allogeneic IBMIR (8).
Thus, we investigated whether coating of pig islets with culture medium. The mixture was incubated for 1.5 h at
room temperature and mixed gently with pipetting everyhuman endothelial cells can inhibit IBMIR in xenograft
environment. 15 min. Coated islets were transferred to 150-mm petri
dishes before transplantation and cultured for 1–9 days.
MATERIALS AND METHODS The coverage of each islet with endothelial cells was
Islet Isolation and Culture examined under fluorescent microscopy and calculated
with an image analysis program (i-solution ver7.3, IMT,The pancreases of adult market pigs were harvested
Korea).at the local slaughterhouse. The splenic lobe of the gland
was rapidly dissected ex situ, immersed in UW solution,
In Vitro Tubing Loop Systemand transported to the islet-processing laboratory. Pan-
Blood donors were healthy without specific diseasecreatic islet isolation and purification were performed as
and had no medication history for 1 month before dona-previously described (10). The islets were cultured free-
tion. The protocol was approved by the Institutional Re-floating in standard culture medium (M199; GIBCO
view Board of Seoul National University Hospital andBRL, Grand Island, NY, USA) supplemented with Earle’s
each subject submitted written informed consent.salts, L-glutamine, 2200 mg/L sodium bicarbonate, 25
A modified tubing loop model (3,7) was used for inmM HEPES buffer, and 10% pig serum. Culture me-
vitro simulation of portal flow. Using an 18-gauge needle,dium was changed every second day. Modified islet cul-
fresh human blood was collected in a surface-heparin-ture medium was manufactured for coculture, and was
ized 60-ml syringe (Corline Systems AB, Uppsala, Swe-made up of M199 and M200 (Cascade Biologics, Port-
den). This blood was transferred to a polyvinyl chlorideland, OR, USA) supplemented with the low serum
(PVC) tube heparinized on the inner surface (Corlinegrowth supplement (LSGS) kit (Cascade Biologics).
Systems AB) (diameter 6.3 mm, length 390 mm) via a
In Vitro Test of Islet Function surface heparinized silicon tube. Each PVC tube was
filled with 7 ml of fresh human blood; 100 µl of PBSGlucose-stimulated insulin release was measured and
was added as a negative control, 5000 IEQ of uncoatedexpressed as the stimulation index (10), calculated as the
islets in 100 µl of PBS were added as a positive control,ratio of stimulated (16.7 mM glucose) to basal (1.67 mM
and 5000 IEQ of endothelial cell coated islets wereglucose) insulin release during 60 min of static incuba-
added as the treatment group. The loops were thention in Krebs’ Ringer bicarbonate HEPES buffer. Insulin
closed and placed in a 37°C incubator on a rocking ap-levels were determined with an insulin immunoradiome-
paratus. Blood was sampled at 0, 5, 15, 30, and 60 min.tric assay kit (Biosource, Nivelles, Belgium).
For the zero time samples, the blood was transferred
Endothelial Cell Preparation directly to EDTA-containing tubes and 1 ml of blood
acquired from the tubing loop was placed in an Eppen-Human aortic endothelial cells (HAEC; Cascade Bio-
dorf tube containing 40 µl of 0.2 M EDTA. About 100logics) were cultured at 37°C in 5% CO2 in M200 me-
µl of blood was used for full blood count analysis, anddium containing 10% FCS, 100 µg/ml penicillin/strepto-
the remaining blood was centrifuged at 4000 × g for 20mycin, and 15 mg/ml of LSGS. Cells were grown to
min at 4°C. After 1-h incubation, all the loop contentsconfluence in 100-mm petri dishes. Medium was changed
were filtered through 70-µm diameter filters (Filcons,every second day. HAEC were used from passages 4–7.
Cuptype; DAKO, Glostrup, Denmark). The remainingThe HAEC were stained with the PKH26 Red Fluores-
filtered blood was collected in EDTA tubes for hemato-cent Cell Linker kit (Sigma, St. Louis, MO, USA) ac-
logic analysis (platelets, lymphocytes, monocytes, andcording to the manufacturer’s instructions.
granulocytes), assays of complement activation (C3a),
Endothelial Cell Coating of Pig Islets and coagulation activation (thrombin–antithrombin (TAT)).
Hematologic analyses were performed by CoulterEndothelial cell coating was performed as previously
described (8), with some modifications. HAEC were ACT-diff analyzer (Beckman Coulter, Miami, FL,
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USA). C3a and TAT were quantified using ELISA assay ing the p-value obtained by the number of comparisons.
Differences with values of p < 0.05 were considered sig-kits (C3a EIA kit: Quidel, San Diego, CA, USA; Enzyg-
nost-TAT kit: Behringwerke, Marburg, Germany). nificant.
RESULTSStatistical Analysis
In Vitro Tests of Islet Function in VariousFor comparison between different blood donors,
Culture Conditionsplatelet counts were transformed to a percentage of the
zero time value. C3a and TAT assay results were trans- The stimulation index of uncoated pig islets in M199
medium was 1.98 ± 0.19 (mean ± SEM, n = 5). Un-formed to a percentage of the positive control value.
Data are presented as mean ± SEM. Mean values were coated islets in modified culture medium showed similar
glucose-stimulated release values (1.95 ± 0.27, n = 5) tocompared using the paired Student t-test. Bonferroni
correction was used for subgroup analysis by multiply- those in M199 medium and the endothelial cells coating
Figure 1. Pig islets coated with human endothelial cells. Endothelial cells were labeled with the fluorescent dye PKH26. An early
phase endothelial cell coated islet under light (A) and fluorescence (B) microscopy. Endothelial cell growth after 1–9 days of
coculture under light (C) or fluorescence (D) microscopy. Magnification ×400.
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to coat pig islets was 10 times higher than that used to
coat human islets. After 1–9 days of coculture, 3.5–
94.5% of coverage was observed (Fig. 1). The degree of
coverage was well correlated with the duration of cocul-
ture.
Blood Clot Formation
Blood clot formation as a result of IBMIR was ob-
served after 1-h incubation (Fig. 2). The volume of
blood clot correlated with decreased platelet, monocyte,
and granulocyte counts. The clot diameter was 11.25 ±
0.80 mm in the positive control (n = 18), 0.86 ± 0.1 mm
in the negative control (n = 18), and 9.12 ± 0.69 mm in
the endothelial cell coated group (p = 0.06, n = 17). TheFigure 2. Differences between groups in the volume of blood
endothelial cell-coated group was subdivided and ana-clots after incubation. After the loop contents were filtered,
islets were left on the filter with different levels of blood clot lyzed by degree of surface coverage by endothelial cells
formation. Horizontal bars represent means. NC: negative con- (≤50% vs. >50%) or coculture time (<5 days vs. ≥ 5
trol tube without islets; PC: positive control tubes with un- days). Unexpectedly, clot formation was more inhibitedtreated islets; EC: endothelial cell coated islets; EC1: endothe-
in the subgroup of coated islets with ≤50% coveragelial cell coated islets with ≤50% coverage; EC2: endothelial
(8.51 ± 0.91 mm, p = 0.390, n = 11) than in those withcell coated islets with >50% coverage.
>50% coverage (10.25 ± 0.92 mm, p = 0.328, n = 6), al-
though this difference was not significant (Fig. 2). Be-
cause the majority of the subgroup of coated islets withprocedure had no harmful effect on insulin secreting ca-
≤50% coverage belonged to the subgroup cocultured forpacity of pig islets (1.96 ± 0.29, n = 5).
<5 days, clot formation was more inhibited in the sub-
Endothelial Cell Coating of Pig Islets group cocultured for <5 days compared to the subgroup
cocultured for ≥ 5 days.In a single-species model (8) using composite human
islet–endothelial cells grafts, the endothelial cells grew
Hematologic Analysesuntil they reached confluence. However, in our two-
species model, human endothelial cells grew very The positive control group showed exhausted plate-
lets and decreased lymphocyte, monocyte, and granulo-slowly on pig islets. This necessitated increase of cocul-
ture time and the ratio of endothelial cells to islets in the cyte counts (Table 1). The endothelial cell coated group
as a whole showed a protective effect on the plateletmixing procedure. The number of endothelial cells used
Table 1. Blood Cell Counts, Complement, and Coagulation Analysis
Positive Total
Negative Control Endothelial Subgroup Subgroup
Initial Control (Untreated Cell-Coated With ≤50% With >50%
Count (No Islets) Islets) Group Coverage Coverage
(0 min, (60 min, (60 min, (60 min, (60 min, (60 min,
n = 18) n = 18) n = 18) n = 18) n = 11) n = 7)
Lymphocytes 100%* 95.2 ± 1.7% 82.9 ± 3.4% 89.1 ± 2.6% 93.6 ± 1.7% 81.9 ± 5.2%
Monocytes 100%* 105.1 ± 7.3% 21.4 ± 4.3% 40.6 ± 8.9%§ 44.8 ± 13.4% 34.0 ± 9.5%
Granulocytes 100%* 98.2 ± 0.8% 34.3 ± 2.5% 56.0 ± 5.2%§ 58.9 ± 6.7%§ 51.5 ± 8.4%
Platelets 100%* 56.7 ± 2.0%† 2.1 ± 0.4% 14.5 ± 4.7%§ 22.5 ± 6.8%¶ 8.9 ± 4.4%
C3a 1.16 ± 0.65% 42.5 ± 3.8% 100%‡ 83.1 ± 4.3%§ 80.1 ± 5.3%§ 88.7 ± 7.7%
TAT 0.01 ± 0.00% 5.7 ± 1.5% 100%‡ 56.2 ± 8.0%§ 46.6 ± 6.8%§ 71.4 ± 16.7%
Values are mean ± SEM. C3a, complement C3a; TAT, thrombin–antithrombin complex.
*The initial baseline count was defined as 100%. Subsequent values were expressed as a percentage of this value.
†Decreased by air and tube contact interaction with blood.
‡The final result of the positive control was defined as 100% and other values were expressed as a percentage of this value.
§Significant difference (p < 0.01) by Student paired t-test compared with positive control.
¶Significant difference (p < 0.05) by Student paired t-test compared with positive control.
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count compared with the positive control (p < 0.01), and
the ≤50% coated subgroup also showed a statistically
significant protective effect on the platelet count (p <
0.05), whereas the >50% coated subgroup did not (Fig.
3A). Similar results were observed only in the subgroup
of cocultured for <5 days.
C3a and TAT ELISA Assays
The endothelial cell-coated group showed signifi-
cantly decreased complement (p < 0.01) and coagulation
(p < 0.01) activation compared to the uncoated group
(Table 1). Subgroup analysis showed that the ≤50%
coated subgroup also showed a significant decrease in
both assays, whereas the >50% coated subgroup did not
(Fig. 3B, C). Similar results were observed in the sub-
group analysis of coculture time.
DISCUSSION
Whereas complement activation mainly occurs sec-
ondary to the activation of the coagulation system in
allogeneic IBMIR (16), porcine islets in human blood
trigger direct complement activation (4,7). Because en-
dothelial cells express various surface protectants such
as complement regulatory protein, heparan sulfate, anti-
thrombin III, tissue factor pathway inhibitor, and throm-
bomodulin, it prevents activation of complement cascade
and coagulation cascade (15). In addition, endothelial
cells prevent platelet aggregation by the release of prost-
acyclin, ectoADPases, thrombomodulin, nitric oxide,
and platelet-derived ADP (15). Furthermore, human en-
dothelial cells coating of pig islets may reduce throm-
botic and inflammatory reaction affected by cross-species
molecular incompatibilities in the pig to human islet
xenotransplantation, because human endothelial cells
express human specific surface protectants such as com-
plement regulatory protein, tissue factor pathway inhibi-
tor, and thrombomodulin (2,6). In this study, we found
human endothelial cell coating of pig islet reduced all
components of xenogeneic IBMIR. Furthermore, there
was no harmful effect of modified culture medium and
endothelial cell coating of pig islets on insulin-secreting
capacity of islets.
The size of blood clot may reflect therapeutic effi-
ciency of the specific strategy chosen for islet protec-Figure 3. The effect of coating pig islets with human endothe-
tion. In this study, blood clot size showed significantlial cells on platelet, complement and coagulation. Samples
were taken at 0, 5, 15, 30, and 60 min. (A) Platelet (B), com- correlation with platelet consumption, and with de-
plement and (C) thrombin–antithrombin analysis was per- creases in monocytes and granulocytes. Furthermore,
formed. Only the subgroup of endothelial cell coated islets clot size must be regarded as an indicator of thrombuswith ≤50% coverage shows significant inhibition of platelet
formation in clinical applications. Because portal veinconsumption, complement, and coagulation activation. Nega-
thrombosis is a critical life-threatening complication,tive control (open boxes), positive control (filled boxes), endo-
thelial cell-coated subgroup with >50% coverage (open trian- some new therapeutic approach should be evaluated to
gles), and endothelial cell-coated subgroup with ≤50% inhibit thrombus formation before practical application.
coverage (filled triangles). *p < 0.05, **p < 0.01. In this study, the protective potency of the subgroup
of islets with ≤50% endothelial cell coverage was simi-
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